StockData
Krystal Biotech, Inc. logo

Krystal Biotech, Inc. (KRYS) stock

KRYSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 11/3052% above fair value
$315.34+16.79 (+5.62%)

Close on Nov 18, 2026Market cap $9.33BP/E 39.5Yield –

Krystal Biotech market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Krystal Biotech's market cap was $9.14B on Nov 11, 2026, against $6.32B a year earlier. Over the last 5 years it ranged from $1.31B to $10.94B, with a median of $4.45B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$9.14B+27.9%
2025Dec 31, 2025$7.15B+58.6%
2024Dec 31, 2024$4.51B+28.8%
2023Dec 29, 2023$3.50B+71.7%
2022Dec 30, 2022$2.04B+30.9%
2021Dec 31, 2021$1.56B+31.6%
2020Dec 31, 2020$1.18B+23.4%
2019Dec 31, 2019$958.50M+320.1%
2018Dec 31, 2018$228.14M+111.8%
2017Dec 29, 2017$107.70M–

More Krystal Biotech figures

See a number that looks wrong?